Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols
Svitlana Tonkovyd, Elena Castro, Stella Lin, Yiyun Tang et al.
Journal
Future Oncology
Topics
Prostate Cancer Treatment and Research
article
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols
Svitlana Tonkovyd, Elena Castro, Stella Lin, Yiyun Tang, Karim Fizazi, Karine Martins da Trindade, Arun A. Azad, Neeraj Agarwal, Daniel J. George, Michael Thomas Schweizer, Amy Bock, Neal D. Shore, Srilakshmi Nekkalapudi, Nitin Shrivastava, Hao Zeng
article en
Abstract
No abstract available for this paper.
Publication Tag
Future Oncology
Institutions
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Duke University (US), Pfizer (United States) (US), University of Washington (US), University of Utah (US), Sichuan University (CN), Université Paris-Saclay (FR), Peter MacCallum Cancer Centre (AU), Star Technology and Research (United States) (US), Fred Hutch Cancer Center (US), Hospital Universitario 12 De Octubre (ES), D’Or Institute for Research and Education (BR), Spanish Oncology Genitourinary Group (ES), Carolina Urologic Research Center (US)